Skip to main content
. 2022 Dec 6;10:1038138. doi: 10.3389/fpubh.2022.1038138

Table 2.

Characteristics of the patients*.

Prescriptions Women (N = 458) Men (N = 443) Total (N = 901)
Age (mean, SD) 64.15 (16.22) 61.01 (15.21) 62.60 (15.80)
Diagnosis records (ICD-10) 404 (88.21%) 406 (91.24%) 808 (89.68%)
Diabetes mellitus type 2 (E10–E14) 151 (32.97%) 212 (47.86%) 363 (40.29%)
Dyslipidemia (E70–E90) 220 (48.03%) 197 (44.47%) 417 (46.28%)
Hypertensive diseases (I10–I15) 275 (60.04%) 262 (59.14%) 537 (59.60%)
Ischemic heart diseases (I20–I25) 30 (6.55%) 58 (13.09%) 88 (9.77%)
Other heart diseases (I30–I52) 29 (6.33%) 33 (7.45%) 62 (6.88%)
Cerebrovascular diseases (I60–I69) 68 (14.85%) 46 (10.38%) 114 (12.65%)
Arterial diseases (I79–I79) 15 (3.28%) 29 (6.55%) 44 (4.88%)
Glomerular diseases (N00–N08) 4 (0.87%) 3 (0.68%) 7 (0.78%)
Acute and chronic kidney failure (N17–N19) 52 (11.35%) 58 (13.09%) 110 (12.21%)
No diagnosis recordsa 54 (11.79%) 39 (8.80%) 93 (10.32%)

SD, standard deviation; ICD, International classification of diseases (49).

*Patients characteristics are described using prescription level as a unit of analysis.

aAbsence of intervention-related diagnosis records in the electronic health records.